BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3021695)

  • 1. CNS relapse despite prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC).
    Hoskin PJ; Yarnold JR; Smith IE; Ford HT
    Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):2025-8. PubMed ID: 3021695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.
    Shaw EG; Su JQ; Eagan RT; Jett JR; Maksymiuk AW; Deigert FA
    J Clin Oncol; 1994 Nov; 12(11):2327-32. PubMed ID: 7964948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effectiveness of "late" and "early" prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.
    Sas-Korczyńska B; Korzeniowski S; Wójcik E
    Strahlenther Onkol; 2010 Jun; 186(6):315-9. PubMed ID: 20495970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
    Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
    Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is prophylactic cranial irradiation indicated in small-cell lung cancer?
    Fleck JF; Einhorn LH; Lauer RC; Schultz SM; Miller ME
    J Clin Oncol; 1990 Feb; 8(2):209-14. PubMed ID: 2153763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS; McCarley DL; Zlotecki RA
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
    Alshehadat S; Sahmoun AE
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice-daily prophylactic cranial irradiation for patients with limited disease small-cell lung cancer with complete response to chemotherapy and consolidative radiotherapy: report of a single institutional phase II trial.
    Wolfson AH; Bains Y; Lu J; Etuk B; Sridhar K; Raub W; Markoe A
    Am J Clin Oncol; 2001 Jun; 24(3):290-5. PubMed ID: 11404503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic cranial irradiation in limited-stage small cell lung cancer.
    Liengswangwong V; Bonner JA; Shaw EG; Foote RL; Frytak S; Richardson RL; Creagan ET; Eagan RT; Su JQ
    Cancer; 1995 Mar; 75(6):1302-9. PubMed ID: 7882280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patterns of relapse in patients with small cell lung cancer--the effect of chest irradiation and prophylactic cranial irradiation combined with intensive chemotherapy on long-term survival].
    Ueoka H; Ohnoshi T; Numata T; Kawahara S; Nishii K; Yonei T; Yamashita H; Moritaka T; Kiura K; Uji H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1581-7. PubMed ID: 1963910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: the Toronto experience.
    Lishner M; Feld R; Payne DG; Sagman U; Sculier JP; Pringle JF; Yeoh JL; Evans WK; Shepherd FA; Maki E
    J Clin Oncol; 1990 Feb; 8(2):215-21. PubMed ID: 2153764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.
    Videtic GM; Truong PT; Dar AR; Yu EW; Stitt LW
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):709-16. PubMed ID: 14529775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
    Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prophylactic brain irradiation in small cell lung cancer treatment.
    Sørensen JB
    Monaldi Arch Chest Dis; 2003; 59(2):128-33. PubMed ID: 14635501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early versus late prophylactic cranial irradiation in patients with extensive small cell lung cancer.
    Chen Y; Li J; Zhang Y; Hu Y; Zhang G; Yan X; Lin Z; Zhao Z; Jiao S
    Strahlenther Onkol; 2018 Oct; 194(10):876-885. PubMed ID: 29774395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
    Komaki R; Shin DM; Glisson BS; Fossella FV; Murphy WK; Garden AS; Oswald MJ; Hong WK; Roth JA; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):807-11. PubMed ID: 7860392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC).
    Gregor A; Cull A; Stephens RJ; Kirkpatrick JA; Yarnold JR; Girling DJ; Macbeth FR; Stout R; Machin D
    Eur J Cancer; 1997 Oct; 33(11):1752-8. PubMed ID: 9470828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.
    De Ruysscher D; Bremer RH; Koppe F; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Pitz C; Simons J; ten Velde G; Dohmen J; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Dehing C; Pijls M; Minken A; Lambin P
    Radiother Oncol; 2006 Sep; 80(3):307-12. PubMed ID: 16949169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
    Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
    J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.